Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Public ClinicalTrials.gov record NCT00658359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Open-label, Active Comparator-controlled, Extension Trial To Evaluate The Long-term Safety And Efficacy Of Cp-690,550 In Renal Allograft Recipients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study that will follow transplant patients from Study A3921030 to monitor for long term safety, tolerability and efficacy for 5 additional years, except in Portugal where the study will follow transplant patients through Month 36 posttransplant. Patients will continue their study medications that were previously assigned.
Study identification
- NCT ID
- NCT00658359
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 178 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2008 (Actual)
- Primary completion
- Mar 2015 (Actual)
- Completion
- Jun 2015 (Actual)
- Last update posted
- Feb 23, 2018
2008 – 2015
United States locations
- U.S. sites
- 37
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Cedars-Sinai MedicalCenter | Los Angeles | California | 90048 | — |
| Ronald Reagan UCLA Medical Center | Los Angeles | California | 90095 | — |
| UCLA Medical Center | Los Angeles | California | 90095 | — |
| Stanford School of Medicine | Palo Alto | California | 94304 | — |
| Stanford University Medical Center | Palo Alto | California | 94305 | — |
| Balboa Institute of Transplantation | San Diego | California | 92123 | — |
| California Institute of Renal Research | San Diego | California | 92123 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| California Pacific Medical Center - Pacific Campus | San Francisco | California | 94115 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| UCSF Medical Center - Long Hospital | San Francisco | California | 94143 | — |
| USCF Medical Center - Connie Frank Transplant Center | San Francisco | California | 94143 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| Yale-New Haven Hospital | New Haven | Connecticut | 06504 | — |
| Yale Physicians Building | New Haven | Connecticut | 06510 | — |
| University Of Florida | Gainesville | Florida | 32610 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| NUCATS's Clinical Research Unit | Chicago | Illinois | 60611 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Hurley Medical Center | Flint | Michigan | 48503 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Investigational Drug Services (IDS) / UNC Healthcare | Chapel Hill | North Carolina | 27514 | — |
| Transplant Clinic/UNC Heathcare | Chapel Hill | North Carolina | 27514 | — |
| UNC Department of Surgery, Clinical Trials Consortium | Chapel Hill | North Carolina | 27599-7211 | — |
| UNC Department of Surgery/Abdominal Transplant Division | Chapel Hill | North Carolina | 27599-7211 | — |
| Division of Pharmacotherapy, School of Pharmacy, University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599-7360 | — |
| University of North Carolina, Department of Medicine/Nephrology | Chapel Hill | North Carolina | 27599 | — |
| Drexel University College of Medicine - Hahnemann University Hospital | Philadelphia | Pennsylvania | 19102 | — |
| Hahnemann University Hospital | Philadelphia | Pennsylvania | 19102 | — |
| Medical University of South Carolina, Department of Transplantation Surgery | Charleston | South Carolina | 29425 | — |
| Nephrology Clinic | Charleston | South Carolina | 29425 | — |
| Dallas Transplant Institute | Dallas | Texas | 75204 | — |
| Annette C. and Harold C. Simmons Transplant Institute at Baylor University Medical Center | Dallas | Texas | 75246 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00658359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 23, 2018 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00658359 live on ClinicalTrials.gov.